Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the scientific evidence underpinning the prohibition of kava-kava under the Medicines for Human Use (Kava-kava) (Prohibition) Order 2002.

The UK Statutory Instrument 2002 No. 3170 The Medicines for Human use (Kava-kava) (Prohibition) Order 2002 prohibits the sale, supply, and importation of Kava-kava for use in unlicensed medicines in the United Kingdom.

The Prohibition Order was reviewed after it had been in force for two years by an Expert Working Group of the Committee on Safety of Medicines, which announced in February 2006 that the prohibition was justified and proportionate and should remain in place. No further review of the prohibition order has been made.

The 2002 Prohibition Order does not exclude applicants applying for a traditional herbal registration or a marketing authorisation under Regulation 125 or Regulation 49, respectively, of the Human Medicines Regulations 2012. Should a traditional herbal registration or a marketing authorisation application for a Kava-kava medicinal product be submitted to the Medicines Healthcare products Regulatory Agency, its safety would be reviewed on an application-specific basis and based on the currently available evidence.